Shares of Merck and Pfizer are way down from their previous peaks. Merck's lead drug, Keytruda, grew sales by 19% last year, but its era of patent-protected exclusivity is approaching its end.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

As MAPS doubles down on its advocacy and movement-building efforts, the psychedelic community will be best served by leadership with the vision and expertise to take this work to new heights.

Construction of a million-square-foot industrial tech facility along Millwood Pike (U.S 50) east of Winchester near Interstate 81 is complete, according to a media release about the project.

SAN FRANCISCO, Calif., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Sciens Building Solutions (“Sciens”) today announced it has welcomed Lorton, Virginia-based Akers Fire Protection (“Akers”) to its ...

Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Night - Freezing rain with a 80% chance of precipitation. Winds variable at 5 to 7 mph (8 to 11.3 kph). The overnight low will be 30 °F (-1.1 °C). Cloudy with a high of 46 °F (7.8 °C) and a 77 ...

Rain with a high of 39 °F (3.9 °C) and a 79% chance of precipitation. Winds from NE to NNE at 8 to 9 mph (12.9 to 14.5 kph). Night - Cloudy with a 49% chance of precipitation. Winds from NNE to ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

Merck & Co has said building its cardiovascular medicines business is central to its strategy to manage the loss of patent protection of cancer juggernaut Keytruda in five years, and new studies ...